1-3 of 3
Leanne McCulloch, PharmD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiac and Pulmonary Safety Profile of Single-Agent Carfilzomib From Four Phase 2 Studies in Patients with Relapsed and/or Refractory Multiple Myeloma

Sagar Lonial, MD, Ruben Niesvizky, MD, Leanne McCulloch, PharmD, Kanya Rajangam, MD, PhD, Ravi Vij, MD
Journal: Blood
Blood (2012) 120 (21): 4037.
https://doi.org/10.1182/blood.V120.21.4037.4037
Published: 2012
Journal Articles

Integrated Safety From Phase 2 Studies of Monotherapy Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma (MM): An Updated Analysis

Seema Singhal, MD, David S. Siegel, MD, PhD, Thomas Martin, MD, Ravi Vij, MD, Luhua Wang, MD, Andrzej J Jakubowiak, MD, Sagar Lonial, MD, Vishal Kukreti, MD, FRCPC, Jeffrey A. Zonder, MD, Alvin F. Wong, PharmD, Leanne McCulloch, PharmD, Ashraf Z. Badros, MD, Ruben Niesvizky, MD, Robert Z. Orlowski, MD, PhD, A. Keith Stewart, MBA, MB, CHB, Debbi Kotlovker, MS, Sundar Jagannath, MD
Journal: Blood
Blood (2011) 118 (21): 1876.
https://doi.org/10.1182/blood.V118.21.1876.1876
Published: 2011
Journal Articles

Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)

Sundar Jagannath, MD, Ravi Vij, MBBS, MD, Jonathan L. Kaufman, MD, Thomas Martin, MD, Ruben Niesvizky, MD, Nashat Y Gabrail, MD, Melissa Alsina, MD, Alvin F. Wong, PharmD, Mai H. Le, MD, Leanne McCulloch, PharmD, Alison L. Hannah, MD, Michael Kauffman, MD, PhD, David Samuel diCapua Siegel, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1953.
https://doi.org/10.1182/blood.V116.21.1953.1953
Published: 2010